
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Last year, a record-breaking number of ARTAS iX hair restoration procedures were performed, proving that there’s never been a better time to offer hair restoration at your clinic. Hair transplantation popularity is on the rise. The industry has increased 16% since 2016 to become a $5 billion market, with over 700,000 procedures performed globally in 2020 alone. As technology improves and surgical methods continue to get better, more men and women are turning to hair restoration as a solution for their hair loss. If hair restoration isn’t something you already offer, or if you’re interested in ramping up your clinic’s ROI on this lucrative procedure, here are the top reasons you should consider ARTAS.
First of all, here’s a primer on how ARTAS iX differs from other hair restoration devices on the market.
The ARTAS iX hair restoration device replaces the old method of manual Follicular Unit Extraction (FUE) with Automated FUE. Like manual FUE, ARTAS iX extracts individual hair follicles from the back or sides of the head using a specialized device and then implants them in the area where more hair growth is desired. However, with the advancement of automated technology, the transplants can be done with better speed and precision, for a more natural-looking result. Additionally, ARTAS iX is enhanced with Artificial Intelligence (AI) to design the ideal extraction and placement of the hair follicles. The innovative system leverages state-of-the-art technology to enable accurate and efficient harvesting, recipient site-making, and implantation functionality in one device, using image-guided robotics for precise and repeatable follicular unit dissection.
There are several reasons this technological advancement is fast replacing the outdated manual FUE method. An automated FUE hair transplant can be done in the same amount of time as a hair transplant using the FUT method, reducing the cost of FUE hair restoration. In addition, our devices use robotics with pneumatic pressure to both extract and reinsert the follicles. This eliminates the need for handling the grafts with forceps. In the hands of an experienced technician, the risk of damage to the transplant area is very low, and uptake of transplanted follicles is very high. The procedure is minimally invasive, less painful, leaves no linear scarring, and requires very little in terms of recovery or aftercare. The newly implanted hair follicles continue the natural hair growth cycle and results improve each week, with full realization at 9-12 months post-procedure.
Automated Follicular Unit Extraction is one of the best developments in the hair replacement field in recent years. Venus Concept’s ARTAS iX takes it one step further, utilizing integrated AI technology for optimal follicular transplantation executed by the device’s seven-axis KUKA robot arm. A high-definition stereoscopic vision system with 44-micron resolution and image-guided robotic alignment technology accurately and precisely harvest each follicular unit at the optimal angle. Combined, these automated innovations deliver repeatable results that can’t be beaten.
During an ARTAS iX treatment, Artificial Intelligence software analyzes and selects appropriate grafts from the donor area accurately, and then identifies and develops optimal recipient sites while simultaneously implanting each harvested graft. At the same time, the device protects the patient’s existing terminal hair, thereby achieving a more natural appearance in both the donor site and the recipient area.
Running the digital media marketing for every service and product you offer at your clinic can be time-consuming, complicated, and expensive. With ARTAS iX, much of the heavy lifting has already been done for you. Because we’re continually positioning our devices as the best in the industry via our vast web presence, promotions, and social media, they already have excellent brand recognition. Your clinic can leverage that recognition to its own benefit by offering clients technology that they already know, respect, and trust.
Unfortunately, many clients are still concerned about the stigma of baldness and undergoing hair restoration treatments. By augmenting the experience with robotics and a futuristic AI program, we hope to change that. In addition, the sleek and compact design of the device itself makes for a statement in any clinic setting. It just looks cool, and that shouldn’t be underestimated.
All of our cutting-edge medical aesthetic devices are backed by Venus Concept’s scientific research and thorough clinical trials. We stand by them, and we want your clinic to succeed as much as you do. We’re here to support your practice through our business enhancement program, our easy-entry subscription plans, and a wealth of expertise in marketing and growing aesthetic businesses. First and foremost, our competitive pricing model excludes hidden fees or pay-per-use gimmicks, allowing you to get the best return on your investment—and to pass those savings onto your clients.
To speak to an expert today about the future of hair restoration and what ARTAS iX can do for your clinic, contact us using the button below.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA and licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite, and licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction. Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is cleared by the FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Fiore™ received regulatory approval in Israel for aesthetic and functional treatment of the vagina, labia and mons pubis. Venus Fiore™ is available for sale in India, Hong Kong, and other selected Asian countries.
The Venus Viva™ MD is cleared by the FDA, licensed by Health Canada and has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin using the Viva™/Viva™ MD applicator, and the non-invasive treatment, reduction in the appearance of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ is cleared by FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction. In the U.S., Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. These indications enable the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright 2023 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More